{"gene":"GPR21","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2023,"finding":"Cryo-EM structures of ligand-free human GPR21 bound to heterotrimeric miniGs and miniG15 proteins revealed that an agonist-like motif in extracellular loop 2 (ECL2) occupies the orthosteric pocket and promotes receptor activation, and that G protein binding is accommodated by a flexible cytoplasmic portion of transmembrane helix 6 (TM6) with little or undetectable outward movement. A side pocket was also identified as a potential new ligand binding site.","method":"Cryo-EM structure determination with functional validation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structures with multiple G protein complexes and structural analysis of activation mechanism","pmids":["36639690"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structure of GPR21 in complex with Gαs revealed that GPR21 can couple to Gαs protein, and structure-guided mutagenesis and biochemical analysis demonstrated that ECL2 is essential for receptor signal transduction via cAMP.","method":"Cryo-EM single-particle analysis, co-expression, mutagenesis, cAMP assay","journal":"MedComm","confidence":"High","confidence_rationale":"Tier 1 — cryo-EM structure combined with mutagenesis and functional cAMP readout","pmids":["36721851"],"is_preprint":false},{"year":2016,"finding":"GPR21 is a constitutively active receptor that couples to Gαq-type G proteins, leading to activation of MAPKs, and overexpression of GPR21 in HEK293T cells markedly attenuated insulin signalling. These effects were reduced in the presence of serum, suggesting a possible native inhibitory ligand.","method":"Overexpression in HEK293T cells, MAPK activation assays, insulin signalling assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — clean cell-based overexpression with multiple signalling readouts in a single lab","pmids":["27243589"],"is_preprint":false},{"year":2011,"finding":"GPR21 knockout mice on high-fat diet were leaner, more insulin-sensitive, showed improved glucose tolerance, and had decreased inflammatory markers (MCP-1, CRP, IP-10), indicating GPR21 plays a role in regulating body weight, glucose metabolism, and inflammatory signalling in vivo.","method":"Knockout mouse model with metabolic phenotyping, ELISA for inflammatory markers","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 — KO mouse with defined metabolic phenotypes, though later work questioned specificity due to possible Rabgap1 co-deletion","pmids":["22155242"],"is_preprint":false},{"year":2021,"finding":"GPR21-selective knockout mice showed impaired chemotactic responses of monocytes and macrophages to MCP-1/CCL2 without altered CCR2 expression, due to dysregulated monocyte polarization. Bone marrow transplantation studies revealed that GPR21's effect on monocyte-driven inflammation and glucose homeostasis operate through divergent, non-overlapping mechanisms.","method":"Selective KO mouse, bone marrow transplantation, chemotaxis assay, high-fat diet feeding, gene expression analysis","journal":"BMJ open diabetes research & care","confidence":"Medium","confidence_rationale":"Tier 2 — selective KO with multiple mechanistic experiments including bone marrow transplant epistasis","pmids":["34782333"],"is_preprint":false},{"year":2021,"finding":"Knockdown of GPR21 by siRNA or treatment with GPR21 inverse agonist GRA2 in HepG2 hepatocytes increased glucose uptake, enhanced GLUT-2 membrane translocation, activated the AKT/GSK-3β insulin signalling pathway, and reduced ERK activation, demonstrating that GPR21 mediates negative regulation of hepatic glucose uptake.","method":"siRNA knockdown, pharmacological inhibition, glucose uptake assay, GLUT-2 membrane fractionation, Western blotting for pAKT, pGSK-3β, pERK","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal loss-of-function approaches with multiple downstream readouts in a single study","pmids":["34639123"],"is_preprint":false},{"year":2025,"finding":"Prex1 maintains Gpr21 at the hepatocyte plasma membrane surface through an adaptor (GEF-independent) function; Gpr21-mediated blockade of hepatic glucose uptake and mitochondrial ATP production requires Prex1, identifying Prex1 as an upstream regulator of Gpr21 trafficking and signalling.","method":"Prex1 KO and catalytically-inactive knock-in mouse models, GPCR trafficking assays, mitochondrial membrane potential/ATP assays, Glut2 surface level measurements","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis with multiple functional readouts, but preprint not yet peer-reviewed","pmids":["bio_10.1101_2025.04.14.648781"],"is_preprint":true}],"current_model":"GPR21 is a constitutively active class-A orphan GPCR whose ECL2 acts as an intrinsic agonist-like motif to occupy the orthosteric pocket and drive coupling to Gαq, Gαs, and G15 proteins (with minimal TM6 outward displacement), leading to MAPK activation and suppression of hepatic insulin/AKT signalling and GLUT-2 surface expression; its surface residence and inhibitory effects on hepatic glucose uptake and mitochondrial ATP production are maintained by the adaptor function of Prex1, while in immune cells GPR21 additionally regulates monocyte polarization and MCP-1-driven chemotaxis through a mechanism distinct from its metabolic role."},"narrative":{"teleology":[{"year":2011,"claim":"The first loss-of-function study established that GPR21 is not merely an orphan receptor but an in vivo regulator of body weight, glucose homeostasis, and systemic inflammation, providing the rationale for investigating its signaling mechanism.","evidence":"GPR21-knockout mice on high-fat diet showed reduced adiposity, improved insulin sensitivity, improved glucose tolerance, and decreased circulating MCP-1/CRP/IP-10","pmids":["22155242"],"confidence":"Medium","gaps":["Possible co-deletion of neighboring gene Rabgap1 questioned specificity of metabolic phenotype","Cell-autonomous versus systemic contribution of GPR21 was not resolved","No signaling pathway was identified downstream of GPR21 in this study"]},{"year":2016,"claim":"Demonstrating that GPR21 is constitutively active and couples to Gαq/MAPK signaling resolved the question of which G-protein pathway it engages and revealed that its activity directly antagonizes insulin signaling at the cellular level.","evidence":"Overexpression of GPR21 in HEK293T cells activated MAPKs and attenuated insulin signaling; serum reduced these effects, suggesting a possible inhibitory ligand","pmids":["27243589"],"confidence":"Medium","gaps":["Constitutive activity was shown only by overexpression, not at endogenous expression levels","The putative serum-borne inhibitory ligand was not identified","Direct interaction between GPR21 and Gαq was not structurally confirmed"]},{"year":2021,"claim":"Two studies in 2021 dissected the downstream mechanism in hepatocytes and separated GPR21's metabolic role from its immune-cell function: GPR21 suppresses hepatic glucose uptake by inhibiting AKT and GLUT-2 translocation, while in monocytes it regulates chemotaxis to MCP-1 via polarization control, independent of CCR2 expression or the metabolic pathway.","evidence":"siRNA knockdown and inverse agonist GRA2 in HepG2 cells increased glucose uptake, GLUT-2 surface levels, and pAKT while reducing pERK; selective KO mice combined with bone marrow transplantation showed non-overlapping immune and metabolic mechanisms","pmids":["34639123","34782333"],"confidence":"Medium","gaps":["The molecular link between GPR21 and monocyte polarization machinery is unknown","GRA2 selectivity was not independently validated by an orthogonal binding assay","Whether GPR21 directly modulates GLUT-2 trafficking or acts indirectly through ERK/AKT balance is unresolved"]},{"year":2023,"claim":"Cryo-EM structures of ligand-free GPR21 in complex with miniGs, miniG15, and Gαs answered how a receptor with no known agonist achieves constitutive activation: ECL2 folds into the orthosteric pocket as an intrinsic agonist-like element, and G-protein coupling occurs with minimal TM6 outward displacement, an atypical activation mechanism among class-A GPCRs.","evidence":"Cryo-EM single-particle analysis of GPR21–G-protein complexes, mutagenesis of ECL2 abolished cAMP production; a druggable side pocket was identified","pmids":["36639690","36721851"],"confidence":"High","gaps":["No exogenous ligand or endogenous inhibitor has been identified that binds the side pocket","Structural basis for Gαq coupling was not captured (only miniGs and miniG15 complexes solved)","Whether ECL2 auto-agonism is regulated by post-translational modification or interacting proteins in vivo is unknown"]},{"year":2025,"claim":"The discovery that Prex1 acts as a GEF-independent adaptor to retain GPR21 at the plasma membrane established the first upstream trafficking mechanism controlling GPR21 surface density and linked this to GPR21-dependent suppression of mitochondrial ATP production, a previously unrecognized downstream effect.","evidence":"Prex1 KO and catalytically-inactive knock-in mice; GPCR surface trafficking assays, mitochondrial membrane potential and ATP measurements, GLUT-2 surface quantification in hepatocytes (preprint)","pmids":["bio_10.1101_2025.04.14.648781"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Direct physical interaction interface between Prex1 and GPR21 has not been mapped","Whether Prex1-dependent trafficking applies in non-hepatic cell types (e.g., monocytes) is untested"]},{"year":null,"claim":"Major open questions include the identity of any endogenous ligand or inverse agonist for GPR21, the structural basis for Gαq coupling, and the molecular mechanism by which GPR21 controls monocyte polarization.","evidence":"","pmids":[],"confidence":"High","gaps":["No endogenous ligand or inverse agonist has been identified despite serum-dependent activity modulation","Gαq-coupled cryo-EM structure has not been determined","The link between GPR21 and monocyte polarization machinery is entirely uncharacterized at the molecular level"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,6]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,5]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[3,5]}],"complexes":[],"partners":["GNAQ","GNAS","GNA15","PREX1"],"other_free_text":[]},"mechanistic_narrative":"GPR21 is a constitutively active class-A orphan G protein-coupled receptor that functions as a negative regulator of insulin signaling and hepatic glucose uptake. Its extracellular loop 2 (ECL2) serves as an intrinsic agonist-like motif that occupies the orthosteric pocket to drive ligand-independent coupling to Gαq, Gαs, and G15, activating MAPK signaling and suppressing AKT/GSK-3β-mediated insulin signaling and GLUT-2 surface expression in hepatocytes [PMID:36639690, PMID:36721851, PMID:27243589, PMID:34639123]. In vivo, GPR21 deletion improves insulin sensitivity, glucose tolerance, and reduces inflammatory markers, while in immune cells GPR21 regulates monocyte polarization and MCP-1-directed chemotaxis through a mechanism separable from its metabolic role [PMID:22155242, PMID:34782333]. Prex1 maintains GPR21 at the hepatocyte plasma membrane through an adaptor function independent of its GEF activity, and this surface retention is required for GPR21-mediated suppression of glucose uptake and mitochondrial ATP production [PMID:bio_10.1101_2025.04.14.648781]."},"prefetch_data":{"uniprot":{"accession":"Q99679","full_name":"Probable G-protein coupled receptor 21","aliases":[],"length_aa":349,"mass_kda":39.5,"function":"Orphan receptor","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q99679/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GPR21","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GPR21","total_profiled":1310},"omim":[{"mim_id":"604106","title":"G PROTEIN-COUPLED RECEPTOR 52; GPR52","url":"https://www.omim.org/entry/604106"},{"mim_id":"601910","title":"G PROTEIN-COUPLED RECEPTOR 22; GPR22","url":"https://www.omim.org/entry/601910"},{"mim_id":"601909","title":"G PROTEIN-COUPLED RECEPTOR 21; GPR21","url":"https://www.omim.org/entry/601909"},{"mim_id":"601908","title":"G PROTEIN-COUPLED RECEPTOR 20; GPR20","url":"https://www.omim.org/entry/601908"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"blood vessel","ntpm":5.1}],"url":"https://www.proteinatlas.org/search/GPR21"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q99679","domains":[{"cath_id":"1.20.1070.10","chopping":"22-229_245-315","consensus_level":"high","plddt":90.0325,"start":22,"end":315}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99679","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q99679-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q99679-F1-predicted_aligned_error_v6.png","plddt_mean":83.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GPR21","jax_strain_url":"https://www.jax.org/strain/search?query=GPR21"},"sequence":{"accession":"Q99679","fasta_url":"https://rest.uniprot.org/uniprotkb/Q99679.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q99679/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q99679"}},"corpus_meta":[{"pmid":"22155242","id":"PMC_22155242","title":"G-protein-coupled receptor GPR21 knockout mice display improved glucose tolerance and increased insulin response.","date":"2011","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22155242","citation_count":28,"is_preprint":false},{"pmid":"36639690","id":"PMC_36639690","title":"Cryo-EM structures of orphan GPR21 signaling complexes.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36639690","citation_count":27,"is_preprint":false},{"pmid":"27243589","id":"PMC_27243589","title":"Regulating the effects of GPR21, a novel target for type 2 diabetes.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27243589","citation_count":19,"is_preprint":false},{"pmid":"36721851","id":"PMC_36721851","title":"Cryo-EM structure of orphan G protein-coupled receptor GPR21.","date":"2023","source":"MedComm","url":"https://pubmed.ncbi.nlm.nih.gov/36721851","citation_count":16,"is_preprint":false},{"pmid":"32583711","id":"PMC_32583711","title":"Modifications in GPR21 and GPR82 genes expression as a consequence of metabolic syndrome etiology.","date":"2020","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/32583711","citation_count":10,"is_preprint":false},{"pmid":"34782333","id":"PMC_34782333","title":"Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms.","date":"2021","source":"BMJ open diabetes research & care","url":"https://pubmed.ncbi.nlm.nih.gov/34782333","citation_count":10,"is_preprint":false},{"pmid":"34639123","id":"PMC_34639123","title":"GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34639123","citation_count":10,"is_preprint":false},{"pmid":"27081476","id":"PMC_27081476","title":"GPR21 KO mice demonstrate no resistance to high fat diet induced obesity or improved glucose tolerance.","date":"2016","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/27081476","citation_count":7,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.14.648781","title":"Prex1 controls glucose homeostasis by limiting glucose uptake and mitochondrial metabolism in liver through GEF-independent regulation of Gpr21","date":"2025-04-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.14.648781","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":5101,"output_tokens":1725,"usd":0.020589},"stage2":{"model":"claude-opus-4-6","input_tokens":5001,"output_tokens":2017,"usd":0.113145},"total_usd":0.133734,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of ligand-free human GPR21 bound to heterotrimeric miniGs and miniG15 proteins revealed that an agonist-like motif in extracellular loop 2 (ECL2) occupies the orthosteric pocket and promotes receptor activation, and that G protein binding is accommodated by a flexible cytoplasmic portion of transmembrane helix 6 (TM6) with little or undetectable outward movement. A side pocket was also identified as a potential new ligand binding site.\",\n      \"method\": \"Cryo-EM structure determination with functional validation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structures with multiple G protein complexes and structural analysis of activation mechanism\",\n      \"pmids\": [\"36639690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of GPR21 in complex with Gαs revealed that GPR21 can couple to Gαs protein, and structure-guided mutagenesis and biochemical analysis demonstrated that ECL2 is essential for receptor signal transduction via cAMP.\",\n      \"method\": \"Cryo-EM single-particle analysis, co-expression, mutagenesis, cAMP assay\",\n      \"journal\": \"MedComm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structure combined with mutagenesis and functional cAMP readout\",\n      \"pmids\": [\"36721851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GPR21 is a constitutively active receptor that couples to Gαq-type G proteins, leading to activation of MAPKs, and overexpression of GPR21 in HEK293T cells markedly attenuated insulin signalling. These effects were reduced in the presence of serum, suggesting a possible native inhibitory ligand.\",\n      \"method\": \"Overexpression in HEK293T cells, MAPK activation assays, insulin signalling assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cell-based overexpression with multiple signalling readouts in a single lab\",\n      \"pmids\": [\"27243589\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GPR21 knockout mice on high-fat diet were leaner, more insulin-sensitive, showed improved glucose tolerance, and had decreased inflammatory markers (MCP-1, CRP, IP-10), indicating GPR21 plays a role in regulating body weight, glucose metabolism, and inflammatory signalling in vivo.\",\n      \"method\": \"Knockout mouse model with metabolic phenotyping, ELISA for inflammatory markers\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse with defined metabolic phenotypes, though later work questioned specificity due to possible Rabgap1 co-deletion\",\n      \"pmids\": [\"22155242\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GPR21-selective knockout mice showed impaired chemotactic responses of monocytes and macrophages to MCP-1/CCL2 without altered CCR2 expression, due to dysregulated monocyte polarization. Bone marrow transplantation studies revealed that GPR21's effect on monocyte-driven inflammation and glucose homeostasis operate through divergent, non-overlapping mechanisms.\",\n      \"method\": \"Selective KO mouse, bone marrow transplantation, chemotaxis assay, high-fat diet feeding, gene expression analysis\",\n      \"journal\": \"BMJ open diabetes research & care\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — selective KO with multiple mechanistic experiments including bone marrow transplant epistasis\",\n      \"pmids\": [\"34782333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Knockdown of GPR21 by siRNA or treatment with GPR21 inverse agonist GRA2 in HepG2 hepatocytes increased glucose uptake, enhanced GLUT-2 membrane translocation, activated the AKT/GSK-3β insulin signalling pathway, and reduced ERK activation, demonstrating that GPR21 mediates negative regulation of hepatic glucose uptake.\",\n      \"method\": \"siRNA knockdown, pharmacological inhibition, glucose uptake assay, GLUT-2 membrane fractionation, Western blotting for pAKT, pGSK-3β, pERK\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal loss-of-function approaches with multiple downstream readouts in a single study\",\n      \"pmids\": [\"34639123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Prex1 maintains Gpr21 at the hepatocyte plasma membrane surface through an adaptor (GEF-independent) function; Gpr21-mediated blockade of hepatic glucose uptake and mitochondrial ATP production requires Prex1, identifying Prex1 as an upstream regulator of Gpr21 trafficking and signalling.\",\n      \"method\": \"Prex1 KO and catalytically-inactive knock-in mouse models, GPCR trafficking assays, mitochondrial membrane potential/ATP assays, Glut2 surface level measurements\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple functional readouts, but preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.04.14.648781\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"GPR21 is a constitutively active class-A orphan GPCR whose ECL2 acts as an intrinsic agonist-like motif to occupy the orthosteric pocket and drive coupling to Gαq, Gαs, and G15 proteins (with minimal TM6 outward displacement), leading to MAPK activation and suppression of hepatic insulin/AKT signalling and GLUT-2 surface expression; its surface residence and inhibitory effects on hepatic glucose uptake and mitochondrial ATP production are maintained by the adaptor function of Prex1, while in immune cells GPR21 additionally regulates monocyte polarization and MCP-1-driven chemotaxis through a mechanism distinct from its metabolic role.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GPR21 is a constitutively active class-A orphan G protein-coupled receptor that functions as a negative regulator of insulin signaling and hepatic glucose uptake. Its extracellular loop 2 (ECL2) serves as an intrinsic agonist-like motif that occupies the orthosteric pocket to drive ligand-independent coupling to Gαq, Gαs, and G15, activating MAPK signaling and suppressing AKT/GSK-3β-mediated insulin signaling and GLUT-2 surface expression in hepatocytes [PMID:36639690, PMID:36721851, PMID:27243589, PMID:34639123]. In vivo, GPR21 deletion improves insulin sensitivity, glucose tolerance, and reduces inflammatory markers, while in immune cells GPR21 regulates monocyte polarization and MCP-1-directed chemotaxis through a mechanism separable from its metabolic role [PMID:22155242, PMID:34782333]. Prex1 maintains GPR21 at the hepatocyte plasma membrane through an adaptor function independent of its GEF activity, and this surface retention is required for GPR21-mediated suppression of glucose uptake and mitochondrial ATP production [PMID:bio_10.1101_2025.04.14.648781].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"The first loss-of-function study established that GPR21 is not merely an orphan receptor but an in vivo regulator of body weight, glucose homeostasis, and systemic inflammation, providing the rationale for investigating its signaling mechanism.\",\n      \"evidence\": \"GPR21-knockout mice on high-fat diet showed reduced adiposity, improved insulin sensitivity, improved glucose tolerance, and decreased circulating MCP-1/CRP/IP-10\",\n      \"pmids\": [\"22155242\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Possible co-deletion of neighboring gene Rabgap1 questioned specificity of metabolic phenotype\",\n        \"Cell-autonomous versus systemic contribution of GPR21 was not resolved\",\n        \"No signaling pathway was identified downstream of GPR21 in this study\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that GPR21 is constitutively active and couples to Gαq/MAPK signaling resolved the question of which G-protein pathway it engages and revealed that its activity directly antagonizes insulin signaling at the cellular level.\",\n      \"evidence\": \"Overexpression of GPR21 in HEK293T cells activated MAPKs and attenuated insulin signaling; serum reduced these effects, suggesting a possible inhibitory ligand\",\n      \"pmids\": [\"27243589\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Constitutive activity was shown only by overexpression, not at endogenous expression levels\",\n        \"The putative serum-borne inhibitory ligand was not identified\",\n        \"Direct interaction between GPR21 and Gαq was not structurally confirmed\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Two studies in 2021 dissected the downstream mechanism in hepatocytes and separated GPR21's metabolic role from its immune-cell function: GPR21 suppresses hepatic glucose uptake by inhibiting AKT and GLUT-2 translocation, while in monocytes it regulates chemotaxis to MCP-1 via polarization control, independent of CCR2 expression or the metabolic pathway.\",\n      \"evidence\": \"siRNA knockdown and inverse agonist GRA2 in HepG2 cells increased glucose uptake, GLUT-2 surface levels, and pAKT while reducing pERK; selective KO mice combined with bone marrow transplantation showed non-overlapping immune and metabolic mechanisms\",\n      \"pmids\": [\"34639123\", \"34782333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The molecular link between GPR21 and monocyte polarization machinery is unknown\",\n        \"GRA2 selectivity was not independently validated by an orthogonal binding assay\",\n        \"Whether GPR21 directly modulates GLUT-2 trafficking or acts indirectly through ERK/AKT balance is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cryo-EM structures of ligand-free GPR21 in complex with miniGs, miniG15, and Gαs answered how a receptor with no known agonist achieves constitutive activation: ECL2 folds into the orthosteric pocket as an intrinsic agonist-like element, and G-protein coupling occurs with minimal TM6 outward displacement, an atypical activation mechanism among class-A GPCRs.\",\n      \"evidence\": \"Cryo-EM single-particle analysis of GPR21–G-protein complexes, mutagenesis of ECL2 abolished cAMP production; a druggable side pocket was identified\",\n      \"pmids\": [\"36639690\", \"36721851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No exogenous ligand or endogenous inhibitor has been identified that binds the side pocket\",\n        \"Structural basis for Gαq coupling was not captured (only miniGs and miniG15 complexes solved)\",\n        \"Whether ECL2 auto-agonism is regulated by post-translational modification or interacting proteins in vivo is unknown\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The discovery that Prex1 acts as a GEF-independent adaptor to retain GPR21 at the plasma membrane established the first upstream trafficking mechanism controlling GPR21 surface density and linked this to GPR21-dependent suppression of mitochondrial ATP production, a previously unrecognized downstream effect.\",\n      \"evidence\": \"Prex1 KO and catalytically-inactive knock-in mice; GPCR surface trafficking assays, mitochondrial membrane potential and ATP measurements, GLUT-2 surface quantification in hepatocytes (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.04.14.648781\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Preprint not yet peer-reviewed\",\n        \"Direct physical interaction interface between Prex1 and GPR21 has not been mapped\",\n        \"Whether Prex1-dependent trafficking applies in non-hepatic cell types (e.g., monocytes) is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include the identity of any endogenous ligand or inverse agonist for GPR21, the structural basis for Gαq coupling, and the molecular mechanism by which GPR21 controls monocyte polarization.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No endogenous ligand or inverse agonist has been identified despite serum-dependent activity modulation\",\n        \"Gαq-coupled cryo-EM structure has not been determined\",\n        \"The link between GPR21 and monocyte polarization machinery is entirely uncharacterized at the molecular level\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 5]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [3, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"GNAQ\",\n      \"GNAS\",\n      \"GNA15\",\n      \"PREX1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}